Navigation Links
MGB Biopharma to Present at Bio-Europe 2013
Date:11/4/2013

GLASGOW, Scotland, November 4, 2013 /PRNewswire/ --

MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that CEO Dr Miroslav Ravic will present at  Bio-Europe 2013  in Vienna, Austria (4-6 November). Details of the presentation on 6 November are listed below.  

Dr Ravic will highlight MGB Biopharma's recent rapid progress in developing a truly novel class of anti-infectives. The Company's lead candidate MGB-BP-3 is an antibacterial active against a broad range of multi-resistant Gram-positive pathogens. The Company has completed preclinical development of an oral formulation that is ready to enter the clinic for Clostridium difficile. In addition, MGB Biopharma is developing an intravenous formulation of MGB-BP-3 for hospital acquired Gram-positive infections and this is expected to be IND-ready by the end of 2014.

MGB-based anti-infectives have the potential to deliver significant advantages over current approaches including broad, bactericidal activity against multi-resistant Gram-positive and Gram-negative pathogens. The platform also promises to deliver compounds that are active against certain viruses, fungi and parasites. MGB's anti-infectives are based on its minor groove binder (MGB) technology platform.

Dr Miroslav Ravic, CEO of MGB Biopharma, said: "Antimicrobial resistance is clearly a major global public health concern. Yet, the lack of truly novel agents, even among late stage candidates, means that, as an industry, we are ill equipped to tackle this problem. We believe that MGB's truly novel minor groove binder technology platform, could for the first time in a more than a decade, provide novel agents that offer a real breakthrough in addressing antimicrobial resistance. In parti
'/>"/>

SOURCE MGB Biopharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
2. PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013
3. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
4. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
5. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
6. CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data Standard Released for Public Review
7. Benu BioVentures to Finance Early Biopharmaceutical Clinical Development
8. Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
9. Recently Patented Technology Poised To Disrupt The Plasma Biopharmaceutical Market
10. Life Cycle Management of Biopharmaceuticals, New Life Science Webinar Hosted by Xtalks
11. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Sciences, Inc. (OTCQB: GBLX), a medical cannabis research and development ... marijuana dispensary locations in Las Vegas, Nevada ... Clark County, Nevada dispensary for which the company ... GrowBLOX Sciences, CEO Craig Ellins stated, "We ... in the City of Las Vegas . ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 a2z Inc. ... ChirpE Mobile App, AACC Pathfinder, in its 2014 ... AACC’s annual meeting is planned for July 29-31, 2014 ... place to be to connect with global leaders in ... management, and other areas of breaking science in laboratory ...
(Date:7/22/2014)... 2014 Even within a phylum so full of mean ... other arthropods for its cruelty -- at least to crickets. ... fly is a most predatory sort of parasite. It swoops ... smear of larvae, and leaves its wicked brood to invade, ... None of this would be possible without the fly,s ability ...
(Date:7/22/2014)... July 22, 2014 Nuclear reactors are ... produced by controlled fission chain reaction in nuclear reactors ... is used to drive a power- generating turbine. Currently ... the world’s total electricity production. Nuclear reactor market is ... construction, planned and proposed nuclear reactor projects. , Early ...
Breaking Biology Technology:GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 2GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 2Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 3
... , , , ... company developing orally available antiviral therapeutics, announced today that Kenneth I. ... , Mr. Moch brings more than ... has played a key role in building several life science companies. ...
... UCSF research papers this week are marking major breakthroughs ... disease that infects more than 200 million people worldwide ... death. One paper documents a multinational success, led ... in England, in sequencing the genome of the Schistosoma ...
... July 15 , Million EUR 2008 08/07 ... MEUR %Sales Var.% MEUR %Sales Var.%, Southern Europe (1) 26.7 71 15 28.5 68 ... Other markets 2.0 5 47 1.5 ... 21 33.8 82 12, SCIT ...
Cached Biology Technology:Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer 2UCSF researchers help crack parasite genome, identify drug leads 2UCSF researchers help crack parasite genome, identify drug leads 3STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained 2STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained 3
(Date:7/23/2014)... has the nasty habit of getting tangled and forming ... and learn how to disentangle them (e.g. useful for ... School for Advanced Studies (SISSA) in Trieste and his ... simulate these knots and their dynamics. In their latest ... , Micheletti together with Marco Di Stefano, first author ...
(Date:7/23/2014)... Security forces worldwide rely on sophisticated equipment, trained ... other public areas against terrorist attacks. A revolutionary ... about to make their job much easier. , ... Patolsky of Tel Aviv University ,s School of ... developed by the Herzliya company Tracense, picks up ...
(Date:7/23/2014)... of the brain is important for encoding ... underlying mechanisms are unclear. Dr. Zhouyan Feng ... the activity of hippocampal neurons in rats ... underlying the neuronal responses. Somatosensory stimulation, in ... field potentials into theta rhythm-dominated waveforms, decreased ...
Breaking Biology News(10 mins):Nano-sized chip "sniffs out" explosives far better than trained dogs 2
... HANOVER, NH In a new study, Dartmouth researchers describe ... virulent nature of Vibrio cholerae , the bacteria that ... find a fatty acid that appears to inhibit ToxT, which ... diarrhea, can be life threatening, and, according to the World ...
... into a run: they switch effortlessly from walking to a ... makes it impossible for them to bounce up in the ... are they running or walking? At a first glance, fast-moving ... Hutchinson from the Royal Veterinary College, UK. But closer analysis ...
... February 11, 2010-Academic programs and courses have increased in ... In a recent study published in the 2010 volume ... Sciences Education, researchers from Cornell University and North ... and experiential learning, which are often a part of ...
Cached Biology News:Dartmouth researchers describe how the cholera bacteria becomes infectious 2Are high speed elephants running or walking? 2Are high speed elephants running or walking? 3Hands-on: From classroom to employment 2
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
Parathyroid Hormone Receptor 2 [PTHR2]...
... Desalt Spin Columns contain a proprietary high-performance ... exceptional desalting and protein-recovery characteristics compared to ... low as 25 g/ml of protein can ... > 95% retention of salts and other ...
Biology Products: